Unclaimed brand
Discover new advanced mental health treatments. Explore innovative therapies, modern care options & personalized solutions. Start your journey today.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#88E0F4
Malibu
136, 224, 244
191, 83, 75
44, 8, 0, 4
#FFCB70
Goldenrod
255, 203, 112
38, 100, 72
0, 20, 56, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
Hope Therapeutics, a subsidiary of NRx Pharmaceuticals, is at the forefront of medical innovation aimed at combatting acute suicidality and depression through its flagship product, NRX-100, an intravenous formulation of ketamine. With a mission to bring hope to over 3.5 million individuals in the United States, the company focuses on therapeutic solutions for a range of mental health conditions, including bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).
Guided by a commitment to scientific excellence, Hope Therapeutics utilizes advanced mechanisms of action involving NMDA and 5HT2A receptors to drive its clinical initiatives. The company actively engages in research and clinical trials, underscoring its dedication to developing impactful therapies supported by robust scientific evidence.
To stay informed about their latest developments, including recent presentations like the keynote address at the Sachs Neuroscience Forum, Hope Therapeutics encourages stakeholders to explore their comprehensive resources and patient stories, reflecting their unwavering commitment to enhancing mental health care.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
The HOPE Therapeutics name, logos and brand assets are trademarks of HOPE Therapeutics and its affiliates. Brandfetch isn't affiliated with or endorsed by HOPE Therapeutics. Their use is subject to HOPE Therapeutics's brand guidelines.
